Pre-clinical Endometrial Tissular Renovation Study

NAUnknownINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 27, 2018

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Asherman Syndrome
Interventions
PROCEDURE

CD133+ cells isolation

Hematopoietic precursors from human donors will be mobilized by administering Colony Stimulating Factors (G-CSF) for 5 days (according to the clinical standard administration) and subsequently CD133+ cells will be isolated and transferred in a murine model.

Trial Locations (1)

Unknown

RECRUITING

Hospital Vall D´Hebron, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Igenomix

INDUSTRY

NCT03665649 - Pre-clinical Endometrial Tissular Renovation Study | Biotech Hunter | Biotech Hunter